0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vectors Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-9H2963
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vectors Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Viral Vectors Market Research Report 2023

Code: QYRE-Auto-9H2963
Report
March 2023
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Viral Vectors Market

The global Viral Vectors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Viral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Viral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Viral Vectors in Cancers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Viral Vectors include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Viral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors.
The Viral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Viral Vectors market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Thermo Fisher Scientific (Brammer Bio)
  • VGXI
  • PlasmidFactory

Segment by Type

  • Retroviral Vectors
  • Lentiviral Vectors
  • Adenoviral Vectors
  • Herpes Simplex Virus Vectors
  • Chimeric Viral Vectors
  • Others

Segment by Application

  • Cancers
  • Inherited Disorders
  • Viral Infections
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vectors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Viral Vectors Market Report

Report MetricDetails
Report NameGlobal Viral Vectors Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Herpes Simplex Virus Vectors
1.2.6 Chimeric Viral Vectors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral Vectors Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors Market Perspective (2018-2029)
2.2 Viral Vectors Growth Trends by Region
2.2.1 Global Viral Vectors Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Vectors Historic Market Size by Region (2018-2023)
2.2.3 Viral Vectors Forecasted Market Size by Region (2024-2029)
2.3 Viral Vectors Market Dynamics
2.3.1 Viral Vectors Industry Trends
2.3.2 Viral Vectors Market Drivers
2.3.3 Viral Vectors Market Challenges
2.3.4 Viral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors Players by Revenue
3.1.1 Global Top Viral Vectors Players by Revenue (2018-2023)
3.1.2 Global Viral Vectors Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors Revenue
3.4 Global Viral Vectors Market Concentration Ratio
3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2022
3.5 Viral Vectors Key Players Head office and Area Served
3.6 Key Players Viral Vectors Product Solution and Service
3.7 Date of Enter into Viral Vectors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors Breakdown Data by Type
4.1 Global Viral Vectors Historic Market Size by Type (2018-2023)
4.2 Global Viral Vectors Forecasted Market Size by Type (2024-2029)
5 Viral Vectors Breakdown Data by Application
5.1 Global Viral Vectors Historic Market Size by Application (2018-2023)
5.2 Global Viral Vectors Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Vectors Market Size (2018-2029)
6.2 North America Viral Vectors Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Viral Vectors Market Size by Country (2018-2023)
6.4 North America Viral Vectors Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors Market Size (2018-2029)
7.2 Europe Viral Vectors Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Viral Vectors Market Size by Country (2018-2023)
7.4 Europe Viral Vectors Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors Market Size (2018-2029)
8.2 Asia-Pacific Viral Vectors Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Viral Vectors Market Size by Region (2018-2023)
8.4 Asia-Pacific Viral Vectors Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vectors Market Size (2018-2029)
9.2 Latin America Viral Vectors Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Viral Vectors Market Size by Country (2018-2023)
9.4 Latin America Viral Vectors Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors Market Size (2018-2029)
10.2 Middle East & Africa Viral Vectors Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Viral Vectors Market Size by Country (2018-2023)
10.4 Middle East & Africa Viral Vectors Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors Introduction
11.1.4 BioReliance Revenue in Viral Vectors Business (2018-2023)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors Business (2018-2023)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors Introduction
11.4.4 UniQure Revenue in Viral Vectors Business (2018-2023)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors Introduction
11.5.4 FinVector Revenue in Viral Vectors Business (2018-2023)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors Introduction
11.6.4 MolMed Revenue in Viral Vectors Business (2018-2023)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors Introduction
11.7.4 MassBiologics Revenue in Viral Vectors Business (2018-2023)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors Business (2018-2023)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors Introduction
11.10.4 Lonza Revenue in Viral Vectors Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors Introduction
11.11.4 Aldevron Revenue in Viral Vectors Business (2018-2023)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors Introduction
11.12.4 Eurogentec Revenue in Viral Vectors Business (2018-2023)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2018-2023)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors Introduction
11.14.4 Biovian Revenue in Viral Vectors Business (2018-2023)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2018-2023)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors Introduction
11.16.4 VGXI Revenue in Viral Vectors Business (2018-2023)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors Business (2018-2023)
11.17.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Viral Vectors Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Retroviral Vectors
    Table 3. Key Players of Lentiviral Vectors
    Table 4. Key Players of Adenoviral Vectors
    Table 5. Key Players of Herpes Simplex Virus Vectors
    Table 6. Key Players of Chimeric Viral Vectors
    Table 7. Key Players of Others
    Table 8. Global Viral Vectors Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Viral Vectors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Viral Vectors Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Viral Vectors Market Share by Region (2018-2023)
    Table 12. Global Viral Vectors Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Viral Vectors Market Share by Region (2024-2029)
    Table 14. Viral Vectors Market Trends
    Table 15. Viral Vectors Market Drivers
    Table 16. Viral Vectors Market Challenges
    Table 17. Viral Vectors Market Restraints
    Table 18. Global Viral Vectors Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Viral Vectors Market Share by Players (2018-2023)
    Table 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2022)
    Table 21. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Viral Vectors Product Solution and Service
    Table 25. Date of Enter into Viral Vectors Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Viral Vectors Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Viral Vectors Revenue Market Share by Type (2018-2023)
    Table 29. Global Viral Vectors Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Viral Vectors Revenue Market Share by Type (2024-2029)
    Table 31. Global Viral Vectors Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Viral Vectors Revenue Market Share by Application (2018-2023)
    Table 33. Global Viral Vectors Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Viral Vectors Revenue Market Share by Application (2024-2029)
    Table 35. North America Viral Vectors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Viral Vectors Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Viral Vectors Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Viral Vectors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Viral Vectors Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Viral Vectors Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Viral Vectors Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Viral Vectors Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Viral Vectors Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Viral Vectors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Viral Vectors Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Viral Vectors Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Viral Vectors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Viral Vectors Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Viral Vectors Market Size by Country (2024-2029) & (US$ Million)
    Table 50. BioReliance Company Detail
    Table 51. BioReliance Business Overview
    Table 52. BioReliance Viral Vectors Product
    Table 53. BioReliance Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 54. BioReliance Recent Development
    Table 55. Cobra Biologics Company Detail
    Table 56. Cobra Biologics Business Overview
    Table 57. Cobra Biologics Viral Vectors Product
    Table 58. Cobra Biologics Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 59. Cobra Biologics Recent Development
    Table 60. Oxford BioMedica Company Detail
    Table 61. Oxford BioMedica Business Overview
    Table 62. Oxford BioMedica Viral Vectors Product
    Table 63. Oxford BioMedica Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 64. Oxford BioMedica Recent Development
    Table 65. UniQure Company Detail
    Table 66. UniQure Business Overview
    Table 67. UniQure Viral Vectors Product
    Table 68. UniQure Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 69. UniQure Recent Development
    Table 70. FinVector Company Detail
    Table 71. FinVector Business Overview
    Table 72. FinVector Viral Vectors Product
    Table 73. FinVector Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 74. FinVector Recent Development
    Table 75. MolMed Company Detail
    Table 76. MolMed Business Overview
    Table 77. MolMed Viral Vectors Product
    Table 78. MolMed Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 79. MolMed Recent Development
    Table 80. MassBiologics Company Detail
    Table 81. MassBiologics Business Overview
    Table 82. MassBiologics Viral Vectors Product
    Table 83. MassBiologics Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 84. MassBiologics Recent Development
    Table 85. Richter-Helm Company Detail
    Table 86. Richter-Helm Business Overview
    Table 87. Richter-Helm Viral Vectors Product
    Table 88. Richter-Helm Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 89. Richter-Helm Recent Development
    Table 90. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 91. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 92. FUJIFILM Diosynth Biotechnologies Viral Vectors Product
    Table 93. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 94. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 95. Lonza Company Detail
    Table 96. Lonza Business Overview
    Table 97. Lonza Viral Vectors Product
    Table 98. Lonza Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 99. Lonza Recent Development
    Table 100. Aldevron Company Detail
    Table 101. Aldevron Business Overview
    Table 102. Aldevron Viral Vectors Product
    Table 103. Aldevron Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 104. Aldevron Recent Development
    Table 105. Eurogentec Company Detail
    Table 106. Eurogentec Business Overview
    Table 107. Eurogentec Viral Vectors Product
    Table 108. Eurogentec Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 109. Eurogentec Recent Development
    Table 110. Cell and Gene Therapy Catapult Company Detail
    Table 111. Cell and Gene Therapy Catapult Business Overview
    Table 112. Cell and Gene Therapy Catapult Viral Vectors Product
    Table 113. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 114. Cell and Gene Therapy Catapult Recent Development
    Table 115. Biovian Company Detail
    Table 116. Biovian Business Overview
    Table 117. Biovian Viral Vectors Product
    Table 118. Biovian Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 119. Biovian Recent Development
    Table 120. Thermo Fisher Scientific (Brammer Bio) Company Detail
    Table 121. Thermo Fisher Scientific (Brammer Bio) Business Overview
    Table 122. Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product
    Table 123. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 124. Thermo Fisher Scientific (Brammer Bio) Recent Development
    Table 125. VGXI Company Detail
    Table 126. VGXI Business Overview
    Table 127. VGXI Viral Vectors Product
    Table 128. VGXI Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 129. VGXI Recent Development
    Table 130. PlasmidFactory Company Detail
    Table 131. PlasmidFactory Business Overview
    Table 132. PlasmidFactory Viral Vectors Product
    Table 133. PlasmidFactory Revenue in Viral Vectors Business (2018-2023) & (US$ Million)
    Table 134. PlasmidFactory Recent Development
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vectors Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Viral Vectors Market Share by Type: 2022 VS 2029
    Figure 3. Retroviral Vectors Features
    Figure 4. Lentiviral Vectors Features
    Figure 5. Adenoviral Vectors Features
    Figure 6. Herpes Simplex Virus Vectors Features
    Figure 7. Chimeric Viral Vectors Features
    Figure 8. Others Features
    Figure 9. Global Viral Vectors Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Viral Vectors Market Share by Application: 2022 VS 2029
    Figure 11. Cancers Case Studies
    Figure 12. Inherited Disorders Case Studies
    Figure 13. Viral Infections Case Studies
    Figure 14. Others Case Studies
    Figure 15. Viral Vectors Report Years Considered
    Figure 16. Global Viral Vectors Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 17. Global Viral Vectors Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 18. Global Viral Vectors Market Share by Region: 2022 VS 2029
    Figure 19. Global Viral Vectors Market Share by Players in 2022
    Figure 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2022)
    Figure 21. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2022
    Figure 22. North America Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. North America Viral Vectors Market Share by Country (2018-2029)
    Figure 24. United States Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Canada Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Europe Viral Vectors Market Share by Country (2018-2029)
    Figure 28. Germany Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. France Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. U.K. Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Italy Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Russia Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Nordic Countries Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Asia-Pacific Viral Vectors Market Share by Region (2018-2029)
    Figure 36. China Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Japan Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. South Korea Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Southeast Asia Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. India Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Australia Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Latin America Viral Vectors Market Share by Country (2018-2029)
    Figure 44. Mexico Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Brazil Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East & Africa Viral Vectors Market Share by Country (2018-2029)
    Figure 48. Turkey Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Saudi Arabia Viral Vectors Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. BioReliance Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 51. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 52. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 53. UniQure Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 54. FinVector Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 55. MolMed Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 56. MassBiologics Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 57. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 58. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 59. Lonza Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 60. Aldevron Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 61. Eurogentec Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 62. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 63. Biovian Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 64. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 65. VGXI Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 66. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2018-2023)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS